Thanks, Buildit, both for your letter to GNBT's management yesterday, which was, in my view, very well written both content wise, as well as tone wise, and your reply to Fanmail's last post. I couldn't agree more, as I stated on here many times, which is why I have given it a thumps down rating, but felt tired of replying to this same old, same old beating of the dead horse, as you called it, otherwise. Thymus also for stepping in on that.
(5)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links